-
mechanism of
action has not been defined. The drug is
being developed by
Biomind Labs. As of
December 2022, it is in the
preclinical research stage of development...
-
development for the
treatment of
depressive disorders. It is
being developed by
Biomind Labs. As of
March 2022, it is in
phase 1
clinical trials. List of investigational...
- The
Mysterious Press, 1991,
Chapter 7,
Peter Hurkos: The
Clown Prince`? "
BiomindSuperPowers.com".
Archived from the
original on
October 7, 2007. "International...
-
hallucinogen –
depressive disorders, fibromyalgia, substance-related
disorders –
Biomind Labs
Esketamine (CLE-100) –
ionotropic glutamate NMDA
receptor antagonist...
-
Pharmaceuticals - AdisInsight". adisinsight.springer.com. "N,N-Dimethyltryptamine -
Biomind Labs - AdisInsight". adisinsight.springer.com. "UE 2343 - AdisInsight"...
-
teaching practices within the
Israeli high
school biology curriculum,
Biomind,
emphasizing open inquiry. The
study identifies teachers'
challenges in...
